Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020

Blood Cancer Journal, Published online: 15 November 2022; doi:10.1038/s41408-022-00750-1Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020

Source: Blood Cancer Journal - November 15, 2022 Category: Hematology Authors: Oliver Van Oekelen Nicole Birrer William Wesson Vincent L. Galate Edward R. Scheffer Cliff Aaron M. Goodman Al-Ola Abdallah Rajshekhar Chakraborty Vinay Prasad Ghulam Rehman Mohyuddin Source Type: research